Skip to main content

A trial to evaluate the safety of long term treatment with nintedanib in patients with scleroderma related lung fibrosis.

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Rheumatology and Immunology

Awarded By

Boehringer Ingelheim Pharmaceuticals, Inc.

Start Date

May 8, 2018

End Date

August 14, 2023
 

Administered By

Medicine, Rheumatology and Immunology

Awarded By

Boehringer Ingelheim Pharmaceuticals, Inc.

Start Date

May 8, 2018

End Date

August 14, 2023